Get the Stockscreener App
6.35
14.42%
-1.07
Palatin Technologies Inc stock is traded at $6.35, with a volume of 31,791.
It is down -14.42% in the last 24 hours and down -41.96% over the past month.
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.
See More
Previous Close:
$7.42
Open:
$7.4
24h Volume:
31,791
Relative Volume:
1.45
Market Cap:
$11.31M
Revenue:
$12.88M
Net Income/Loss:
$-6.25M
P/E Ratio:
-4.6459
EPS:
-1.3668
Net Cash Flow:
$-14.98M
1W Performance:
-29.52%
1M Performance:
-41.96%
6M Performance:
-70.85%
1Y Performance:
+0.00%
1-Day Range:
$6.35
$8.00
1-Week Range:
$7.25
$9.20
52-Week Range:
$6.35
$31.00
Palatin Technologies Inc Stock (PTN) Company Profile
Name
Palatin Technologies Inc
Sector
Industry
Phone
609-495-2200
Address
4B CEDAR BROOK DRIVE, CRANBURY
Compare PTN vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PTN
Palatin Technologies Inc
|
6.35 | 11.31M | 12.88M | -6.25M | -14.98M | -1.3668 |
VRTX
Vertex Pharmaceuticals Inc
|
508.71 | 128.94B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
238.63 | 95.27B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
799.98 | 82.36B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
855.28 | 53.79B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.53 | 42.37B | 5.76B | 514.49M | 1.10B | 4.4813 |
Palatin Technologies Inc Stock (PTN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-25 | Initiated | Laidlaw | Buy |
| Dec-03-25 | Initiated | Alliance Global Partners | Buy |
| Jun-05-15 | Reiterated | Canaccord Genuity | Buy |
| Jan-12-15 | Reiterated | ROTH Capital | Buy |
| May-23-12 | Initiated | Noble Financial | Buy |
| Jan-23-07 | Initiated | Next Generation | Buy |
View All
Palatin Technologies Inc Stock (PTN) Latest News
Palatin Reports First Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update - Lelezard
Palatin Technologies Earnings Call: Science vs. Cash - TipRanks
Palatin (PTN) Q4 2026 Earnings Call Transcript - The Globe and Mail
Earnings call transcript: Palatin Technologies posts progress in Q4 2026, shares volatile - Investing.com
Earnings call transcript: Palatin Technologies posts progress in Q4 2026, shares volatile - Investing.com Canada
Palatin Reports Fiscal Year 2026 Financial Results and Provides Business Update - PR Newswire
A $7.5 million cash balance is not expected to cover a year of operations, Palatin says - stocktitan.net
Palatin Reports Fiscal Year 2026 Financial Results and Provides Business Update - TradingView
Palatin Reports Fiscal Year 2026 Financial Results and Provides Business Update - Nasdaq
Palatin Technologies (PTN) Slips 5.89% to $10.22 as Shares Approach Key SupportSector Neutral Pair - dars.gov.et
Palatin Technologies (PTN) Slips 5.89% to $10.22 as Shares Approach Key SupportMotive Wave - dars.gov.et
Palatin Technologies (PTN) Slips 5.89% to $10.22 as Shares Approach Key SupportTriple Bottom - www.dars.gov.et
Palatin Technologies, Inc. Common Stock (NYSE: PTN) Share Price, PTN Stock News, PTN Share Price & Updates - Kalkine
Palatin Technologies, Inc. Common Stock (Backpack Securities) (PTN) Price Prediction & Forecast 20262030 - BeInCrypto
PTN to SGD: Palatin Technologies, Inc. Common Stock (Backpack Securities) Price in Singapore Dollar - CoinGecko
Palatin Technologies, Inc. Common Stock (Backpack Securities) Price History: Download PTN Historical Data - CoinGecko
Palatin Technologies, Inc. Common Stock (Backpack Securities) (PTN) Price, MarketCap, Charts and Fundamentals Info - BeInCrypto
Palatin Technologies, Inc. Common Stock (Backpack Securities) (PTN) Price Prediction for 2026 to 2031 - Bybit
Palatin Technologies, Inc. Common Stock (Backpack Securities) (PTN) Price Prediction for 2026 to 2031 - Bybit
Palatin Technologies, Inc. Common Stock (NYSE: PTN) Share Price, PTN Stock News, PTN Share Price & Updates - kalkine.ca
Palatin Technologies, Inc. Common Stock (Backpack Securities) Price - Bybit
Palatin Technologies Stock Price Forecast. Should You Buy PTN? - StockInvest.us
Palatin Technologies Inc. (PTN) Peer Comparison – Compare with Others - valueresearchonline.com
Palatin Technologies, Inc. Common Stock (Backpack Securities) - CoinGecko
Debt to equity ratio of Palatin Technologies, Inc. – NASDAQ:PTN - TradingView
Palatin Technologies Inc. (PTN) Key Financial Ratios – Valuation, Profitability & More - Value Research
Palatin (PTN): Ends Down by 7.23% at $9.69 at the Close; Next Session: Price Remains Between $9.21 Support and $10.17 Resistance under the Current SnapshotSchiff Line - vinanet.vn
Palatin Technologies, Inc. Common Stock (NASDAQ: PTN) Share Price, PTN Stock News, PTN Share Price & Updates - kalkine.ca
Palatin Technologies, Inc. Common Stock (NASDAQ: PTN) Share Price, PTN Stock News, PTN Share Price & Updates - Kalkine
Palatin Technologies (PTN) gains 4.7% stake holder AuGC BioFund in 13G/A - Stock Titan
PTN Q2 2026 Earnings: Loss of -$0.37 per Share Beats Estimates by 70.54%; Shares Jump 27.46%Analyst Consensus Shift - vinanet.vn
Palatin Technologies Inc (PTN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Palatin Technologies Inc (PTN) Stock News Today - TradingKey
StreetWatch: A $2.9 Billion Takeover Put a Spotlight on Relentless Hunger. Palatin Technologies Is Developing the Next Generation of the Drug That Seeks to Treat It - Nasdaq
Q3 2026 Palatin Technologies Inc Earnings Call Transcript - GuruFocus
StreetWatch: A $2.9 Billion Takeover Put a Spotlight on Relentless Hunger. Palatin Technologies Is Developing the Next Generation of the Drug That Seeks to Treat It - Barchart.com
StreetWatch: A $2.9 Billion Takeover Put a Spotlight on Relentless Hunger. Palatin Technologies Is Developing the Next Generation of the Drug That Seeks to Treat It - Yahoo Finance
Palatin Technologies (PTN) director granted new 2,900-share stock option - stocktitan.net
Palatin Technologies (PTN) director receives 2,400 new stock options - stocktitan.net
Palatin Technologies (PTN) director receives 2,200 options at $7.70 - stocktitan.net
Palatin Technologies Shareholders Back Governance and Incentive Plan - The Globe and Mail
Palatin Technologies Shareholders Back Governance and Incentive Plan - TipRanks
PTN Q2 2026 Earnings: Significant EPS Beat Amid Pipeline Progress and Cost DisciplineEarnings Recovery Stocks - dars.gov.et
Palatin Technologies (PTN) Slides 3.3% as Biotech Sector Faces HeadwindsRisk Reversal - vinanet.vn
Palatin Technologies Surges 10.7%: Key Levels to Watch for PTNBearish Sentiment - siam.in
Palatin Technologies Inc (PTN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Palatin Technologies Inc (PTN) Balance Sheet - TradingKey
Palatin Technologies Inc (PTN) Income Statement - TradingKey
Palatin Technologies Inc (PTN) Institutional Confidence - TradingKey
TradingKey - TradingKey
Palatin Technologies Inc Stock (PTN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Palatin Technologies Inc Stock (PTN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| WILLS STEPHEN T | Director |
Dec 24 '25 |
Proposed Sale |
16.74 |
565 |
9,461 |
0 |
1.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):